+Search query
-Structure paper
| Title | Determining the molecular and physiological actions of subtype-selective nanobodies of GABA receptors. |
|---|---|
| Journal, issue, pages | Sci Adv, Vol. 12, Issue 31, Page eaeg3548, Year 2026 |
| Publish date | Jul 31, 2026 |
Authors | Jose Enrique Gonzalez-Prada / Sulin Liu / Chuhan Shang / Chloe S Chernoff / Damian P Bright / Martin Mortensen / Charlotte F Jones / Stephanie Nestorow / Vikram Babu Kasaragod / Wan-Na Chen / Saad Hannan / Jianchong Zhou / Alexander W E Dunn / Asma Soltani / Richard J Turner / Natasha M Duggan / Yin Yuan / Ayla A Wahid / Steven W Hardwick / Suzanne Scott / Dimitri Y Chirgadze / Els Pardon / Jan Steyaert / A Radu Aricescu / Ole Paulsen / David Belin / Trevor G Smart / Paul S Miller / ![]() |
| PubMed Abstract | γ-Aminobutyric acid type-A (GABA) receptors are the principal mediators of inhibitory neurotransmission in the human central nervous system. The α- and α-containing subtypes have tightly ...γ-Aminobutyric acid type-A (GABA) receptors are the principal mediators of inhibitory neurotransmission in the human central nervous system. The α- and α-containing subtypes have tightly controlled spatial expression profiles, which influence anxiety, nociception, epilepsy, and autism. α/α-Selective small molecules compromise on strength of effect (efficacy) to avoid off-subtype modulation. To break this pharmacological deadlock, we study here a panel of nanobodies (NBs) raised against α- and α-containing GABA receptors. We identify subtype selective silent binders, positive allosteric modulators (PAMs), and inhibitors. Cryo-electron microscopy structures explain the binding modes and molecular mechanisms of action of representative NBs. Modulators exhibit distinct synaptic and extrasynaptic functional profiles in brain slices and neuronal networks and can reduce anxiety in vivo. These selective and efficacious NBs (whether inhibitors or positive modulators) enable strong yet precise pharmacological control of α/α-containing subtypes to advance basic research and as potential therapeutic leads to treat neuropsychiatric disorders. |
External links | Sci Adv / PubMed:42525743 / PubMed Central |
| Methods | EM (single particle) |
| Resolution | 2.52 - 3.45 Å |
| Structure data | EMDB-53206, PDB-9qjp: EMDB-53207, PDB-9qjq: EMDB-53208, PDB-9qjr: EMDB-53209, PDB-9qjs: EMDB-53212, PDB-9qjv: EMDB-53213, PDB-9qjx: EMDB-53214, PDB-9qjy: EMDB-53215, PDB-9qk0: EMDB-53216, PDB-9qk1: EMDB-56081, PDB-9tnb: EMDB-56094, PDB-9tns: EMDB-56109, PDB-9tpq: |
| Chemicals | ![]() ChemComp-NAG: ![]() ChemComp-ABU: ![]() ChemComp-HSM: ![]() ChemComp-HOH: ![]() ChemComp-H0Z: |
| Source |
|
Keywords | MEMBRANE PROTEIN / pLGIC GABA Neurotransmission / pLGIC / GABA / Neurotransmission |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors

External links




























homo sapiens (human)

Keywords